Extent of and reasons for nonuse of implantable cardioverter defibrillator devices in clinical practice among eligible patients with left ventricular systolic dysfunction

Circulation: Cardiovascular Quality and Outcomes

Volumn 4, Issue 2, 2011, Pages 146-151

  Allen LaPointe, Nancy M ^a,b   Al Khatib, Sana M ^a,b   Piccini, Jonathan P ^a,b   Atwater, Brett D ^a,b   Honeycutt, Emily ^b   Thomas, Kevin ^a,b   Shah, Bimal R ^a,b   Zimmer, Louise O ^a,b   Sanders, Gillian ^a,b   Peterson, Eric D ^a,b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Defibrillation; Disparities; Outcomes research

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BILLING AND CLAIMS; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEALTH INSURANCE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE SYSTOLIC DYSFUNCTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC DYSFUNCTION; TREATMENT REFUSAL;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ARRHYTHMIAS, CARDIAC; CARDIAC RESYNCHRONIZATION THERAPY; CONTINENTAL POPULATION GROUPS; DEFIBRILLATORS, IMPLANTABLE; ELIGIBILITY DETERMINATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEART FAILURE, SYSTOLIC; HUMANS; INSURANCE, HEALTH; MALE; MIDDLE AGED; REGISTRIES; SEX CHARACTERISTICS; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79959762552     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.110.958603     Document Type: Article

References (17)

1. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med. 1997;337:1576-1583.
2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237. (Pubitemid 40110811)
3. Bokhari F, Newman D, Greene M, Korley V, Mangat I, Dorian P. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of A subset of patients in the Canadian Implantable Defibrillator Study (CIDS). Circulation. 2004;110:112-116. (Pubitemid 38924577)
4. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999;341:1882-1890.
5. Ezekowitz JA, Armstrong PW, McAlister FA. Implantable cardioverter defibrillators in primary and secondary prevention: A systematic review of randomized, controlled trials. Ann Intern Med. 2003;138:445-452.
6. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335: 1933-1940. (Pubitemid 26428217)
7. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of A defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883. (Pubitemid 34984635)
8. Ezekowitz JA, Rowe BH, Dryden DM, Hooton N, Vandermeer B, Spooner C, McAlister FA. Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction. Ann Intern Med. 2007;147:251-262. (Pubitemid 351664582)
9. Chan PS, Chow T, Kereiakes D, Schloss EJ, Waller T, Eagle K, Hayward RA, Vijan S. Effectiveness of implantable cardioverter-defibrillators in patients with ischemic heart disease and left ventricular dysfunction. Arch Intern Med. 2006;166:2228-2233. (Pubitemid 44753827)
10. Chan PS, Nallamothu BK, Spertus JA, Masoudi FA, Bartone C, Kereiakes DJ, Chow T. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention. Circ Cardiovasc Qual Outcomes. 2009;2:16-24.
11. Curtis LH, Al-Khatib SM, Shea AM, Hammill BG, Hernandez AF, Schulman KA. Sex differences in the use of implantable cardioverterdefibrillators for primary and secondary prevention of sudden cardiac death. J Am Med Assoc. 2007;298:1517-1524. (Pubitemid 47529385)
12. Groeneveld PW, Heidenreich PA, Garber AM. Trends in implantable cardioverter-defibrillator racial disparity: the importance of geography. J Am Coll Cardiol. 2005;45:72-78. (Pubitemid 40052029)
13. Hernandez AF, Fonarow GC, Liang L, Al-Khatib SM, Curtis LH, LaBresh KA, Yancy CW, Albert NM, Peterson ED. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. J Am Med Assoc. 2007;298: 1525-1532. (Pubitemid 47529386)
14. Shah B, Hernandez AF, Liang L, Al-Khatib SM, Yancy CW, Fonarow GC, Peterson ED. Get With The Guidelines Steering Committee. Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry. J Am Coll Cardiol. 2009;53:416-422.
15. Thomas KL, Al-Khatib SM, Kelsey RC II, Bush H, Brosius L, Velazquez EJ, Peterson ED, Gilliam FR. Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of-35%. Am J Cardiol. 2007;100:924-929. (Pubitemid 47368097)
16. Chan PS, Birkmeyer JD, Krumholz HM, Spertus JA, Nallamothu BK. Racial and gender trends in the use of implantable cardioverterdefibrillators among Medicare beneficiaries between 1997 and 2003. Congest Heart Fail. 2009;15:51-57.
17. Gauri AJ, Davis A, Hong T, Burke MC, Knight BP. Disparities in the use of primary prevention and defibrillator therapy among blacks and women. Am J Med. 2006;119:167 e117-e121.